CELL ONCOL - CELLULAR ONCOLOGY

Publications

  1. 2022
  2. Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy

    Viol, F., Sipos, B., Fahl, M., Clauditz, T. S., Amin, T., Kriegs, M., Nieser, M., Izbicki, J. R., Huber, S., Lohse, A. W. & Schrader, J., 12.2022, In: CELL ONCOL. 45, 6, p. 1401-1419 19 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2021
  4. YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models

    Böckelmann, L. C., Felix, T., Calabrò, S. & Schumacher, U., 10.2021, In: CELL ONCOL. 44, 5, p. 1183-1195 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers

    Blessin, N. C., Li, W., Mandelkow, T., Jansen, H. L., Yang, C., Raedler, J. B., Simon, R., Büscheck, F., Dum, D., Luebke, A. M., Hinsch, A., Möller, K., Menz, A., Bernreuther, C., Lebok, P., Clauditz, T., Sauter, G., Marx, A., Uhlig, R., Wilczak, W., Minner, S., Krech, T., Fraune, C., Höflmayer, D., Burandt, E. & Steurer, S., 08.2021, In: CELL ONCOL. 44, 4, p. 793-803 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. 2020
  7. Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

    Blessin, N. C., Spriestersbach, P., Li, W., Mandelkow, T., Dum, D., Simon, R., Hube-Magg, C., Lutz, F., Viehweger, F., Lennartz, M., Fraune, C., Nickelsen, V., Fehrle, W., Göbel, C., Weidemann, S., Clauditz, T., Lebok, P., Möller, K., Steurer, S., Izbicki, J. R., Sauter, G., Minner, S., Jacobsen, F., Luebke, A. M., Büscheck, F., Höflmayer, D., Wilczak, W., Burandt, E. & Hinsch, A., 06.2020, In: CELL ONCOL. 43, 3, p. 421-430 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review